| 000 | 01173 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516181630.0 | ||
| 264 | 0 | _c20140716 | |
| 008 | 201407s 0 0 eng d | ||
| 022 | _a2042-6313 | ||
| 024 | 7 |
_a10.2217/cer.13.14 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurgess, Stephen | |
| 245 | 0 | 0 |
_aUsing Mendelian randomization to assess and develop clinical interventions: limitations and benefits. _h[electronic resource] |
| 260 |
_bJournal of comparative effectiveness research _cMay 2013 |
||
| 300 |
_a209-12 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBiomedical Research |
| 650 | 0 | 4 | _aCausality |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xstatistics & numerical data |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMendelian Randomization Analysis |
| 650 | 0 | 4 | _aPatient Safety |
| 650 | 0 | 4 |
_aPharmacogenetics _xmethods |
| 650 | 0 | 4 | _aRisk Assessment |
| 700 | 1 | _aMalarstig, Anders | |
| 773 | 0 |
_tJournal of comparative effectiveness research _gvol. 2 _gno. 3 _gp. 209-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/cer.13.14 _zAvailable from publisher's website |
| 999 |
_c23270529 _d23270529 |
||